5/6
07:26 am
sabs
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors [Yahoo! Finance]
Low
Report
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors [Yahoo! Finance]
5/6
07:15 am
sabs
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
Low
Report
SAB Biotherapeutics Appoints Jay Skyler, MD, to the Board of Directors
4/16
02:03 pm
sabs
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Medium
Report
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
4/16
08:00 am
sabs
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
Low
Report
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $25.00 price target on the stock.
4/16
07:18 am
sabs
SAB Biotherapeutics Provides SAB-142 Trial Update [Yahoo! Finance]
Low
Report
SAB Biotherapeutics Provides SAB-142 Trial Update [Yahoo! Finance]
4/16
07:15 am
sabs
SAB Biotherapeutics Provides SAB-142 Trial Update
Medium
Report
SAB Biotherapeutics Provides SAB-142 Trial Update
4/8
07:19 am
sabs
SAB Biotherapeutics to Present at INNODIA Annual Meeting [Yahoo! Finance]
Low
Report
SAB Biotherapeutics to Present at INNODIA Annual Meeting [Yahoo! Finance]
4/8
07:15 am
sabs
SAB Biotherapeutics to Present at INNODIA Annual Meeting
Low
Report
SAB Biotherapeutics to Present at INNODIA Annual Meeting
4/4
07:24 am
sabs
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference [Yahoo! Finance]
Low
Report
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference [Yahoo! Finance]
4/4
07:15 am
sabs
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
Low
Report
SAB Biotherapeutics to Present at the Needham Virtual Healthcare Conference
4/2
10:05 am
sabs
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its price target raised by analysts at Chardan Capital from $3.00 to $25.00. They now have a "buy" rating on the stock.
Medium
Report
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its price target raised by analysts at Chardan Capital from $3.00 to $25.00. They now have a "buy" rating on the stock.
4/2
09:01 am
sabs
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its price target lowered by analysts at HC Wainwright from $10.00 to $6.00. They now have a "buy" rating on the stock.
Medium
Report
SAB Biotherapeutics, Inc. (NASDAQ: SABS) had its price target lowered by analysts at HC Wainwright from $10.00 to $6.00. They now have a "buy" rating on the stock.
4/1
07:18 am
sabs
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
Medium
Report
SAB Biotherapeutics Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
3/29
07:30 am
sabs
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
Medium
Report
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results [Yahoo! Finance]
3/29
07:15 am
sabs
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
Medium
Report
SAB Biotherapeutics Reports Full Year 2023 Operating and Financial Results
3/25
10:19 am
sabs
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment [Yahoo! Finance]
High
Report
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment [Yahoo! Finance]
3/25
10:15 am
sabs
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
High
Report
SAB Biotherapeutics Announces Clinical Partnership with Naval Medical Research Center to Advance Potential Influenza Treatment
2/23
08:08 am
sabs
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference [Yahoo! Finance]
Low
Report
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference [Yahoo! Finance]
2/23
08:00 am
sabs
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference
Low
Report
SAB Biotherapeutics to Present at the BIO CEO & Investor Conference